High inherited risk predicts age-associated increases in fibrosis in patients with MASLD
dc.catalogador | aba | |
dc.contributor.author | Díaz, Luis Antonio | |
dc.contributor.author | Alazawi, William | |
dc.contributor.author | Agrawal, Saaket | |
dc.contributor.author | Arab, Juan Pablo | |
dc.contributor.author | Arrese, Marco | |
dc.contributor.author | Idalsoaga, Francisco | |
dc.contributor.author | Barreyro, Fernando Javier | |
dc.contributor.author | Gadano, Adrián | |
dc.contributor.author | Marciano, Sebastián | |
dc.contributor.author | Martínez Morales, Jorge | |
dc.contributor.author | Villela Nogueira, Cristiane | |
dc.contributor.author | Leite, Nathalie | |
dc.contributor.author | Alves Couto, Claudia | |
dc.contributor.author | Theodoro, Rafael | |
dc.contributor.author | Dias Monteiro, Mísia Joyner de Sousa | |
dc.contributor.author | Oliveira, Claudia P. | |
dc.contributor.author | Pessoa, Mario G. | |
dc.contributor.author | Reis Alvares-da-Silva, Mario | |
dc.contributor.author | Madamba, Egbert | |
dc.contributor.author | Bettencourt, Ricki | |
dc.contributor.author | Richards, Lisa M. | |
dc.contributor.author | Majithia, Amit R. | |
dc.contributor.author | Khera, Amit V. | |
dc.contributor.author | Loomba, Rohit | |
dc.contributor.author | Ajmera, Veeral | |
dc.date.accessioned | 2025-05-16T18:31:35Z | |
dc.date.available | 2025-05-16T18:31:35Z | |
dc.date.issued | 2025 | |
dc.description.abstract | Background & AimsLimited data have prevented routine genetic testing from being integrated into clinical practice in metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to quantify the effect of genetic variants on changes in fibrosis severity per decade in MASLD.MethodsThis cross-sectional study included prospectively recruited adults with MASLD aged 18–70 who underwent magnetic resonance elastography (MRE) and genotyping for PNPLA3, TM6SF2, MBOAT7, GCKR, and HSD17B13. A genetic risk score (GRS) was calculated as the sum of established risk alleles in PNPLA3 minus protective variants in HSD17B13 (0=low risk, 1=high risk). We also estimated the polygenic risk score-hepatic fat content (PRS-HFC) and the adjusted version (PRS-5). The primary endpoint was the age-related change in liver stiffness measurement (LSM) on MRE by GRS. Findings were validated using an external cohort from Latin America.ResultsAmong 570 participants, the median age was 57 [49–64] years, 56.8% were women, and 34.2% were Hispanic. Median MRE was 2.4 [2.1–3.0] kPa, and 51% had high GRS. High GRS was independently associated with increased LSM (β=0.28 kPa, 95%CI:0.12–0.44, p=0.001) per 10-year age increase, while the low GRS group showed no significant difference. Similar findings were observed using PRS-HFC and PRS-5. PNPLA3 genotype alone also predicted higher LSM (C/G: β=0.32 kPa, 95%CI:0.02–0.61, p=0.034; G/G: β=0.87 kPa, 95%CI:0.52–1.22, p<0.0001) and G/G genotype was associated with significantly higher LSM by age 44, which was consistent in the validation population.ConclusionGRS, PRS-HFC, PRS-5, and PNPLA3 genotypes alone are associated with greater fibrosis per decade, resulting in divergent disease trajectories starting in midlife. Assessing genetic risk in MASLD will identify high-risk patients who require more frequent monitoring." | |
dc.format.extent | 42 páginas | |
dc.fuente.origen | ORCID | |
dc.identifier.doi | 10.1016/j.jhep.2025.04.035 | |
dc.identifier.eissn | 1600-0641 | |
dc.identifier.issn | 0168-8278 | |
dc.identifier.uri | https://doi.org/10.1016/j.jhep.2025.04.035 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/104347 | |
dc.information.autoruc | Escuela de Medicina; Diaz Piga, Luis Antonio; 0000-0002-8540-4930; 179253 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.revista | Journal of Hepatology | |
dc.rights | acceso restringido | |
dc.subject | NAFLD, non-alcoholic fatty liver disease | |
dc.subject | Metabolic dysfunction-associated fatty liver disease | |
dc.subject | MAFLD | |
dc.subject | Non-alcoholic cirrhosis | |
dc.subject | Cirrhosis | |
dc.subject | Steatotic liver disease | |
dc.subject | Genetic risk score | |
dc.subject | Screening | |
dc.subject | PNPLA3 | |
dc.subject | Noninvasive tests | |
dc.subject | NITs | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.title | High inherited risk predicts age-associated increases in fibrosis in patients with MASLD | |
dc.type | preprint | |
sipa.codpersvinculados | 179253 | |
sipa.trazabilidad | ORCID;2025-05-07 |